{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T07:53:42Z","timestamp":1740124422140,"version":"3.37.3"},"reference-count":21,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2017,8,23]],"date-time":"2017-08-23T00:00:00Z","timestamp":1503446400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European J of Haematology"],"published-print":{"date-parts":[[2017,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Eculizumab\u2010treated paroxysmal nocturnal hemoglobinuria (<jats:styled-content style=\"fixed-case\">PNH<\/jats:styled-content>) patients (pts) show a dramatic decrease in serum lactate dehydrogenase (<jats:styled-content style=\"fixed-case\">LDH<\/jats:styled-content>) activities and bilirubin concentrations. However, some pts remain hyperbilirubinemic, possibly indicating an inadequate response due to extravascular hemolysis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Mutation analyses of hepatocanalicular transporter\/nuclear receptor variants (<jats:italic><jats:styled-content style=\"fixed-case\">ABCB<\/jats:styled-content>4, <jats:styled-content style=\"fixed-case\">ABCB<\/jats:styled-content>11, <jats:styled-content style=\"fixed-case\">ATP<\/jats:styled-content>8B1, <jats:styled-content style=\"fixed-case\">NR<\/jats:styled-content>1H4<\/jats:italic>) were performed in eight (five of eight males; mean age 38\u00a0years [range 26\u201068\u00a0years]) out of the 174 pts with <jats:styled-content style=\"fixed-case\">PNH<\/jats:styled-content>\/\u2010clone at our department due to a persistent increase in total bilirubin concentrations (median 3.4\u00a0mg\/<jats:styled-content style=\"fixed-case\">dL<\/jats:styled-content>; range 2.1\u20108.1\u00a0mg\/<jats:styled-content style=\"fixed-case\">dL<\/jats:styled-content>) during chronic eculizumab treatment and normal\/or slightly increased serum aminotransferase activities. Median observation time was 70.1\u00a0months (range 10.6\u2010135.2\u00a0months). All pts were treated according to German PNH guidelines.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Homozygous and heterozygous procholestatic variants in the <jats:italic><jats:styled-content style=\"fixed-case\">ABCB<\/jats:styled-content>4<\/jats:italic>,<jats:italic> <jats:styled-content style=\"fixed-case\">ABCB<\/jats:styled-content>11,<\/jats:italic> and <jats:italic><jats:styled-content style=\"fixed-case\">ATP<\/jats:styled-content>8B1<\/jats:italic> genes were identified in all eight pts. All carried the common <jats:italic><jats:styled-content style=\"fixed-case\">ABCB<\/jats:styled-content>4<\/jats:italic> c.787A&gt;T polymorphism. The A(<jats:styled-content style=\"fixed-case\">TA<\/jats:styled-content>)<jats:sub>7<\/jats:sub><jats:styled-content style=\"fixed-case\">TAA<\/jats:styled-content> variant in the <jats:italic><jats:styled-content style=\"fixed-case\">UGT<\/jats:styled-content>1A1<\/jats:italic> promoter causing Gilbert syndrome was detected in three pts (5\/8).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Hyperbilirubinemia in <jats:styled-content style=\"fixed-case\">PNH<\/jats:styled-content> pts treated with eculizumab might not only be due to an insufficient response but rather a combination of mutations in hepatocanalicular transporter variants, Gilbert syndrome, and extravascular hemolysis. Our findings warrant further studies concerning transporter and enzyme variants in <jats:styled-content style=\"fixed-case\">PNH<\/jats:styled-content> to determine their clinical significance.<\/jats:p><\/jats:sec>","DOI":"10.1111\/ejh.12927","type":"journal-article","created":{"date-parts":[[2017,7,10]],"date-time":"2017-07-10T15:12:52Z","timestamp":1499699572000},"page":"350-356","source":"Crossref","is-referenced-by-count":4,"title":["Persisting hyperbilirubinemia in patients with paroxysmal nocturnal hemoglobinuria (<scp>PNH<\/scp>) chronically treated with eculizumab: The role of hepatocanalicular transporter variants"],"prefix":"10.1111","volume":"99","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7530-8892","authenticated-orcid":false,"given":"Ferras","family":"Alashkar","sequence":"first","affiliation":[{"name":"Department of Hematology West German Cancer Center University Hospital Essen University of Duisburg\u2010Essen  Essen Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susanne N.","family":"Weber","sequence":"additional","affiliation":[{"name":"Department of Medicine II Saarland University Medical Center Saarland University  Homburg Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Colin","family":"Vance","sequence":"additional","affiliation":[{"name":"Rheinisch\u2010Westf\u00e4lisches Institut f\u00fcr Wirtschaftsforschung  Essen Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D\u00f6rte","family":"Herich\u2010Terh\u00fcrne","sequence":"additional","affiliation":[{"name":"Department of Hematology West German Cancer Center University Hospital Essen University of Duisburg\u2010Essen  Essen Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulrich","family":"D\u00fchrsen","sequence":"additional","affiliation":[{"name":"Department of Hematology West German Cancer Center University Hospital Essen University of Duisburg\u2010Essen  Essen Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank","family":"Lammert","sequence":"additional","affiliation":[{"name":"Department of Medicine II Saarland University Medical Center Saarland University  Homburg Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"R\u00f6th","sequence":"additional","affiliation":[{"name":"Department of Hematology West German Cancer Center University Hospital Essen University of Duisburg\u2010Essen  Essen Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2017,8,23]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.12520"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.2011.01701.x"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(93)90250-T"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02983211"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02983209"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-06-094136"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-11-189944"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2009.007229"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00439-004-1183-x"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-011-0867-y"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-010-0493-0"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-11-189944"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.sbi.2008.09.007"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.biochem.71.102301.093055"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbalip.2005.10.006"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.113.056358"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2009.04.009"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.1998.00472.x"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.2008.00030.x"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1502950"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2013.406"}],"container-title":["European Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fejh.12927","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ejh.12927","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,24]],"date-time":"2023-09-24T08:13:58Z","timestamp":1695543238000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/ejh.12927"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,23]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["10.1111\/ejh.12927"],"URL":"https:\/\/doi.org\/10.1111\/ejh.12927","archive":["Portico"],"relation":{},"ISSN":["0902-4441","1600-0609"],"issn-type":[{"type":"print","value":"0902-4441"},{"type":"electronic","value":"1600-0609"}],"subject":[],"published":{"date-parts":[[2017,8,23]]}}}